You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Mendeley readers
Chapter title |
Ex Vivo Dual Perfusion of the Human Placenta: Disease Simulation, Therapeutic Pharmacokinetics and Analysis of Off-Target Effects
|
---|---|
Chapter number | 14 |
Book title |
Preeclampsia
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7498-6_14 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7497-9, 978-1-4939-7498-6
|
Authors |
Paul Brownbill, Neil Sebire, Erin V. McGillick, Stacey Ellery, Padma Murthi, Brownbill, Paul, Sebire, Neil, McGillick, Erin V., Ellery, Stacey, Murthi, Padma |
Abstract |
In recent years ex vivo dual perfusion of the human placental lobule is seeing an international renaissance in its application to understanding fetal health and development. Here, we discuss the methods and uses of this technique in the evaluation of (1) vascular function, (2) transplacental clearance, (3) hemodynamic and oxygenation changes associated with pregnancy complications on placental structure and function, and (4) placental toxicology and post-perfusion evaluation of tissue architecture. |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 28% |
Student > Bachelor | 4 | 14% |
Student > Ph. D. Student | 4 | 14% |
Student > Doctoral Student | 3 | 10% |
Professor | 1 | 3% |
Other | 2 | 7% |
Unknown | 7 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 24% |
Biochemistry, Genetics and Molecular Biology | 4 | 14% |
Agricultural and Biological Sciences | 2 | 7% |
Engineering | 2 | 7% |
Immunology and Microbiology | 1 | 3% |
Other | 3 | 10% |
Unknown | 10 | 34% |